My Diabetes Information Blogs
Diabetes Medication Galvus Approved in Europe
European Union drug regulators approved a drug for the treatment of diabetes last week that may never make it to American pharmacies. Galvus is a much anticipated medication that may offer new benefits to millions of people with diabetes.
In the
Galvus is a new DPP-4 inhibitor that helps the beta cells in the pancreas produce more insulin. Januvia is another, similar DPP-4 inhibitor that has been approved in Europe and the United States. To read more about Galvus' approval in the European Union, click here.
